Demand for the generic drug dexamethasone has surged in a matter of days since researchers in the U.K. reported that the steroid reduced deaths in very sick Covid-19 patients, according to a major drug-purchasing firm. Orders for dexamethasone surpassed 2.8 million last week as the University of Oxford released study results on June 16, up from nearly 397,500 the prior week, which was more typical, according to Vizient Inc., one of the largest group-purchasing organizations in the U.S. for hospitals. On the day the study was...

Source: Wall Street Journal June 25, 2020 09:56 UTC